Prognostic significance of Ki-67, p53, and Bcl-2 expression in prostate cancer patients with lymph node metastases: A retrospective immunohistochemical analysis

Pathology International

Volumn 48, Issue 1, 1998, Pages 41-46

  Hosaka, Masahiko ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Bcl 2; Immunohistochemistry; Ki 67; p53; Prostatic neoplasms

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER;

EID: 0031924710     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1998.tb03826.x     Document Type: Article

References (2)

1. Borning CC, Squires TS, Tong T. Caner statistics 1994. CA Cancer J. Clin. 1994; 44:7-26.
2. Montie JE. Current prognostic factors for prostate carcinoma. Cancer 1996; 78: 341-344.